OptiBiotix signs deal with massive chemist chain in India
9th Dec 2021 15:37
(Sharecast News) - OptiBiotix Health said on Thursday that its India subsidiary has signed an exclusive sales agreement with one of the leading hospital and pharmacy chains in the country, Apollo Hospitals Enterprises, for the sale of its 'GoFigure' weight management product range in India.
Read moreOptiBiotix Health forms operating subsidiary in India
17th Nov 2021 10:56
(Sharecast News) - Life sciences company OptiBiotix Health announced the formation of its new India subsidiary OptiBiotix Health India (OHI) on Wednesday.
Read moreDirector dealings: Optibiotix CEO ups stake
1st Sep 2021 15:46
(Sharecast News) - Optibiotix Health revealed on Wednesday that chief executive René Kamminga had purchased 8,188 ordinary shares in the AIM-listed life sciences firm.
Read moreOptiBiotix extends deal with Seed Health to other territories
10th Aug 2021 11:24
(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has extended the territories of its original agreement with Seed Health, for the production, promotion, marketing and commercialisation of products containing 'LPLDL'.
Read moreOptiBiotix revenues see healthy rise in first half
5th Aug 2021 13:43
(Sharecast News) - Obesity, cardiovascular and diabetes-focussed life sciences company OptiBiotix Health reported first-half total invoiced sales of 'LPLDL' and 'SlimBiome' as ingredient or final product of £1.074m in an update on Thursday, representing a year-on-year increase of 44.3% and ahead of its expectations for the period.
Read moreOptiBiotix operating losses narrow as revenue surges
17th Jun 2021 12:13
(Sharecast News) - Life sciences company OptiBiotix Health reported a 104% improvement in its full-year revenue on Thursday, to £1.52m.
Read moreOptibiotix names René Kamminga as CEO of subsidiary
23rd Mar 2021 08:06
(Sharecast News) - Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.
Read moreOptiBiotix grants LPLDL licence to Canada's Genuine Health
18th Nov 2020 12:23
(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has granted a non-exclusive licence for 'LPLDL' to Genuine Health, for a cardiovascular health product in Canada and the United States.
Read moreOptiBiotix products launch into retail in Australia, New Zealand
12th Oct 2020 14:00
(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.
Read moreOptiBiotix shares rise as partner Seed gets FDA approval
2nd Oct 2020 10:17
(Sharecast News) - Life sciences company OptiBiotix Health announced on Friday that one of its partners, Seed Health, has received US Food and Drug Administration authorisation for an investigational new drug (IND) application for 'DS-01'.
Read moreOptiBiotix revenue improves fivefold in first half
24th Sep 2020 12:25
(Sharecast News) - Life sciences company OptiBiotix Health reported first-half revenue growth to £0.74m in its first half on Thursday, which was a five times increase in revenues from the first half of 2019.
Read moreOptiBiotix enters new licensing deal with HiLife Vitamins
22nd Sep 2020 10:05
(Sharecast News) - Life sciences company OptiBiotix Health has entered into a non-exclusive license agreement for 'SlimBiome Medical' with HiLife Vitamins & Herbs, it announced on Tuesday.
Read moreOptiBiotix Health strikes deal with Ayalla in Brazil
17th Sep 2020 08:57
(Sharecast News) - Life sciences company OptiBiotix Health announced on Thursday that its wholly-owned subsidiary ProBiotix Health has entered into an exclusive distribution agreement with Ayalla Marketing, for the distribution of its cholesterol reducing probiotic 'LPLDL' as an ingredient and as four finished products within the 'CholBiome' portfolio, for Brazil.
Read moreOptiBiotix signs manufacturing deal with unnamed US firm
15th Sep 2020 08:49
(Sharecast News) - Life sciences company OptiBiotix Health has entered into an agreement with an unnamed US company, it announced on Tuesday, for the large-scale manufacture and commercialisation of a number of 'SweetBiotix' products.
Read moreOptiBiotix Health extends terms of licence agreement with OptiPharm
5th Aug 2020 15:42
(Sharecast News) - Life sciences company OptiBiotix Health has extended the terms of its original exclusive licence agreement for 'OptiBiome' with OptiPharm, it said on Wednesday, which was initially announced on 31 March.
Read more